J Korean Med Assoc Search

CLOSE


J Korean Med Assoc > Volume 53(3); 2010 > Article
Park: Cancer Pain Management - Opioids

Abstract

Opioids are the most effective analgesics for cancer pain treatments. But the ineffective treatment of cancer pain is often related to insufficient knowledge of opioids and fear of the addiction along with the side effects. To achieve effective treatment of cancer pain with opioids, we need a careful assessment of pain, proper use of opioids and regular review of the effectiveness of prescribed opioids. Basic principles of opioids therapy in cancer pain are ① Oral opioids (or transdermal) if possible; ② Combination of long-acting opioids for constant pain with short-acting opioids for breakthrough pain; ③ "Opioids rotation"in poor analgesia and significant side effects with the calculations of the morphine equivalent daily dose (MEDD) ④ Initiation of prophylactic treatment for constipation and nausea. In this review, I will describe the essential aspects of opioids therapy, pharmacology, rotation, properties of the individual opioids, and management of common side effects.

References

1. Mikhail F, Madhuri A, Allen WB. The role of opioids in cancer pain management. Pain Practice 2005;5:43-54.

2. World Health organization. Cancer pain relief 1996;2nd ed. Geneva: WHO office of Publication.

3. Indelicato RA, Portenoy RK. Opioid rotation in the management of refractory cancer pain. J Clin Oncol 2002;20:348-352.

4. Bruera E, Kim HN. Cancer Pain. JAMA 2003;290:2476-2479.

5. Gourlay GK. Treatment of cancer pain with transdermal fentanyl. Lancet Oncol 2001;2:165-172.

Figure 1
Opioids rotation.
jkma-53-250-g001-l.jpg
Table 1
Classification of cancer pain
jkma-53-250-i001-l.jpg
Table 2
Classification of opioid analgesics
jkma-53-250-i002-l.jpg
Table 3
Characteristics of opioids for moderate to severe pain
jkma-53-250-i003-l.jpg

*IR: immediate release, CR: controlled release

**M3G: Morphine-3-glucuronide, M6G: Morphine-6-glucuronide

***SSRI: Selective serotonin uptake inhibitors

Table 4
Transdermal fentanyl dosing (Fentanyl patch; oral morphine=1 : 150)
jkma-53-250-i004-l.jpg
Table 5
Opioids rotation (ex: From oxycodone to transdermal fentanyl)
jkma-53-250-i005-l.jpg
Table 6
From morphine to transdermal fentanyl
jkma-53-250-i006-l.jpg
Table 7
From transdermal fentanyl to morphine.
jkma-53-250-i007-l.jpg
Table 8
Equianalgesic dose of opioids
jkma-53-250-i008-l.jpg

Example; Morphine (IV/SC)10 mg=Morphine (PO)25 mg *, Oxycodone (PO)15 mg=Morphine (PO)10 mg **



ABOUT
ARTICLE CATEGORY

Browse all articles >

ARCHIVES
FOR CONTRIBUTORS
Editorial Office
37 Ichon-ro 46-gil, Yongsan-gu, Seoul
Tel: +82-2-6350-6562    Fax: +82-2-792-5208    E-mail: jkmamaster@gmail.com                

Copyright © 2024 by Korean Medical Association.

Developed in M2PI

Close layer
prev next